What's new

Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 44, Status: Authorised

Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 44, Status: Authorised

May 7, 2025 - 07:57
 0
Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 44, Status: Authorised
Human medicines European public assessment report (EPAR): Herceptin, trastuzumab, Date of authorisation: 28/08/2000, Revision: 44, Status: Authorised
Read More

Tags:

Previous Article

Volvo XC70 is returning as extended-range plug-in hybrid

Next Article

Ørsted halts work on vast UK wind farm citing rising costs

Related Posts

Human medicines European public assessment report (EPAR): Vectibix, panitumumab, Date of authorisation: 03/12/2007, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR...

May 7, 2025  0

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 29, 2025  0

Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0